Evolving Treatment Paradigm in Advanced Non-Small-Cell Lung Cancer

Download these slides providing the latest on the rapidly evolving treatment paradigm for patients with advanced NSCLC
Matthew Gubens, MD, MS
Format: Microsoft PowerPoint (.ppt)
File Size: 2.96 MB
Released: June 23, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Produced in collaboration with
Grace Logo
Supported by educational grants from
Bristol-Myers Squibb
Celgene Corporation
Loxo Oncology, Inc. a wholly owned subsidiary of Eli Lilly and Company

Related Content

EHR data analysis from ASCO 2021 showed that NGS testing and clinical trial participation were less likely among Black patients with NSCLC than White patients, as reported by Clinical Care Options (CCO)

Released: June 15, 2021

Download these expert-selected slides on testing for TRK fusions in your patients with cancer, from Clinical Care Options (CCO).

George D. Demetri, MD Released: June 11, 2021

Download these expert-selected slides on slides on treating patients with NTRK-positive tumors with TRK inhibitors, from Clinical Care Options (CCO).

Alexander Drilon, MD Released: June 11, 2021

Download these expert-selected slides on slides on overcoming acquired resistance with TRK inhibitors, from Clinical Care Options (CCO).

Theodore Laetsch, MD Released: June 11, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue